|
Post by ltta on Mar 23, 2019 10:22:20 GMT -5
I vote for both... we'll know more in a few more months. Eagle will be 1,000 scripts max, unless Mannkind changes the plan.
EDIT --- I just remembered that MC said Eagle Pharmacy was not included in scripts..... so....
I think what Mike said is that Eagle sales are not included in "Symphony" scripts. But, they may be included in these "institutional" scripts. But, if they are, then this program is nowhere near 1000 scripts, and so, apparently not very successful. Unless, maybe they were slow to get started shipping the Rx's in Feb for some reason. In which case, March numbers should have a big jump. I hope otherottawaguy is able to update these numbers again with March numbers. That will be interesting.
"Symphony" scripts are the "scripts" we are talking about.
If Mike said Eagle sales were not included in "Symphony" scripts, then they are not included in "institutional" sales. BECAUSE institutional sales are included in Symphony scripts weekly report.
The Institutional sales numbers are just a breakout of data to view non-retail sales.
See xanet's post above.
|
|
|
Post by MnkdWASmyRtrmntPlan on Mar 23, 2019 11:31:04 GMT -5
Right. Somehow I skipped over Xanat's post. Institutional sales are included in Symphony.
|
|
|
Post by boca1girl on Mar 23, 2019 11:35:24 GMT -5
So if I read this correctly, this is over and above the other numbers we look at every month. Regardless if that is true or not, the good thing is that is shows increased acceptance into hospitals and mail-orders. I doubt that prisons use Afrezza at this time or anytime soon... lolI would think prisons would be a good place to use NEEDLE FREE Insulin.
|
|
|
Post by hellodolly on Mar 23, 2019 14:39:06 GMT -5
So if I read this correctly, this is over and above the other numbers we look at every month. Regardless if that is true or not, the good thing is that is shows increased acceptance into hospitals and mail-orders. I doubt that prisons use Afrezza at this time or anytime soon... lolI would think prisons would be a good place to use NEEDLE FREE Insulin. Personally working in the next best thing to a prison, the County Jail, of which there are two locations in my county...with a meager 2,500 current enrollee's I'm not sure, based on meal time corrections and dosing, that Dreamboats would be an allowable device, even though a needle is 10X more dangerous. Now, before you jump in..."control and security" is a huge part of the mission and administering their doses is done while the inmate is in their cell (part of the control aspect). The only time they go to the 'clinic' is for a new problem, or...follow up to an old problem but not an ONGOING problem 'like' diabetes. However, a prison is a different animal altogether. I'm just not sure if the hurdle is the delivery device or the obstacle of having to bring down a box of dreamboats, medical staff to sit in a cafeteria, different doses..and of course the monitoring aspect? When do you take it? How would you know if you need more? How many pricks are they going to do everyday, for every PWD in a prison at every meal? Logistically, it's how can they do it? I would think a hospital is a better environment because the patient is hooked up to several devices that can constantly monitor the patient. Boca...I'm just rambling out loud. Heading up to Gardens Mall tonight for some dinner at Brio and some Macy's shopping. Lunch was at Dune Deck in Manalapan, as it is every Saturday. Should've been out on my boat but, that's tomorrow.
|
|
|
Post by cedafuntennis on Mar 24, 2019 2:58:16 GMT -5
So if I read this correctly, this is over and above the other numbers we look at every month. Regardless if that is true or not, the good thing is that is shows increased acceptance into hospitals and mail-orders. I doubt that prisons use Afrezza at this time or anytime soon... lolPrisons would be an ideal market. There are a significant number of PWD and pre-diabetes in prison. There are obvious concerns about needle use and access. Afrezza would be ideally suited to help the patients while maintaining a safe environment for medical practitioners and others. From a marketing perspective, it is a highly controlled niche market that could easily be targeted and monopolized. Frankly, this idea came up before, and I'm not sure why MNKD has not assigned a "special" sales force to tackle it. A rather meager expense to dedicate someone to hold a conference for prison medical staff. MNKD could sell direct to boost volumes and profits while providing Afrezza at deep discounts for the publicity. They could use the anonymized data about the controlled population group in various ways to benefit everyone. It could be viewed as a kind of community service for both MNKD and prisoner volunteers.
All very good points but cost is prohibitive at this time vs metformine. Unless it can better proven that it saves money in other diabetes induced deteriorations in the prison population, I would not want tax payer dollars used to improve the quality of life of criminals any more than it already does.
|
|
|
Post by itellthefuture777 on Mar 24, 2019 12:02:57 GMT -5
Prisons would be an ideal market. There are a significant number of PWD and pre-diabetes in prison. There are obvious concerns about needle use and access. Afrezza would be ideally suited to help the patients while maintaining a safe environment for medical practitioners and others. From a marketing perspective, it is a highly controlled niche market that could easily be targeted and monopolized. Frankly, this idea came up before, and I'm not sure why MNKD has not assigned a "special" sales force to tackle it. A rather meager expense to dedicate someone to hold a conference for prison medical staff. MNKD could sell direct to boost volumes and profits while providing Afrezza at deep discounts for the publicity. They could use the anonymized data about the controlled population group in various ways to benefit everyone. It could be viewed as a kind of community service for both MNKD and prisoner volunteers.
All very good points but cost is prohibitive at this time vs metformine. Unless it can better proven that it saves money in other diabetes induced deteriorations in the prison population, I would not want tax payer dollars used to improve the quality of life of criminals any more than it already does. Metformin doesn't halt progression....
|
|
|
Post by cedafuntennis on Mar 24, 2019 12:56:57 GMT -5
All very good points but cost is prohibitive at this time vs metformine. Unless it can better proven that it saves money in other diabetes induced deteriorations in the prison population, I would not want tax payer dollars used to improve the quality of life of criminals any more than it already does. Metformin doesn't halt progression.... True, it does not. But prisons are not free hospitals for criminals and not their responsibility to halt anything. The after many better places to use Afrezza to treat and halt diabetes than prisons and other contributors listed a long list of very good reasons than just cost.
|
|
|
Post by sportsrancho on Mar 24, 2019 13:07:55 GMT -5
diatribe.org/issues/45/logbook Behind bars with diabetes. Just a small portion of the article.... No prison will ever be known for excellent health care, but every prisoner is entitled to adequate health care – a Constitutional right under the Eighth Amendment’s ban against cruel and unusual punishment. What’s more, the Federal Bureau of Prisons has issued guidelines for the management of diabetes – type 1, type 2, and gestational – which are to be followed by each federal prison in America. The document, most recently updated in 2012, is 50 pages and quite thorough, covering everything from “Definite Indications for Insulin as Initial Therapy” to “Cardinal Signs of Periodontitis.” It also stipulates that frequent monitoring of blood glucose (three times a day) is optimal for a diabetic patient on insulin. Sense August of last year, Jay has been at the medium-security prison in Leavenworth, Kansas. (He transferred from Butner so he could be closer to his family.) He cannot keep his insulin or syringes in his cell but must go to the health center. His problem is the schedule: he is forced to take his insulin injections several hours after his meals (the prison requires a nurse to give them to him), ensuring sharp blood sugar spikes several times a day. He eats breakfast at 6:30 a.m. but does not receive his morning injection until 8 a.m. (5 units of Regular; 20 units of NPH). He eats lunch at 11:30 a.m. but does not get his next shot until 3 p.m. (5 units of Regular), a full 3 ½ hours after his meal. This pattern repeats itself in the evening, when he eats supper at 5 p.m. but cannot take his insulin until 8 p.m. (5 Regular, 18 NPH).
|
|
|
Post by otherottawaguy on Mar 25, 2019 12:55:33 GMT -5
Sorry can't really say what Institutional Sales are but suspect it is large volume buyers. The number are reported separately and are also reported together with our usual weekly numbers on a monthly total sales basis.
OOG
|
|
|
Post by mango on Apr 9, 2019 1:31:59 GMT -5
So if I read this correctly, this is over and above the other numbers we look at every month. Regardless if that is true or not, the good thing is that is shows increased acceptance into hospitals and mail-orders. I doubt that prisons use Afrezza at this time or anytime soon... lolPrisons would be an ideal market. There are a significant number of PWD and pre-diabetes in prison. There are obvious concerns about needle use and access. Afrezza would be ideally suited to help the patients while maintaining a safe environment for medical practitioners and others. From a marketing perspective, it is a highly controlled niche market that could easily be targeted and monopolized. Frankly, this idea came up before, and I'm not sure why MNKD has not assigned a "special" sales force to tackle it. A rather meager expense to dedicate someone to hold a conference for prison medical staff. MNKD could sell direct to boost volumes and profits while providing Afrezza at deep discounts for the publicity. They could use the anonymized data about the controlled population group in various ways to benefit everyone. It could be viewed as a kind of community service for both MNKD and prisoner volunteers.
My best friend helped saved the life of a person w/ T1D while he was in prison. The situation is very real, and it is not good. I brought it up w/ Vdex last year, and I really think they would be really great for this kind of thing. It is a niche population like you say, and it is something that needs to happen. There's no reason for it not to other than some chit ADA has to say. I've got a few connections here in MS to at least get the ball rolling (state reps, reform organization, etc),, just waiting on the Afrezza Army to show up.
|
|
|
Post by bigchungus91354 on Apr 9, 2019 9:34:41 GMT -5
diatribe.org/issues/45/logbook Behind bars with diabetes. Just a small portion of the article.... No prison will ever be known for excellent health care, but every prisoner is entitled to adequate health care – a Constitutional right under the Eighth Amendment’s ban against cruel and unusual punishment. What’s more, the Federal Bureau of Prisons has issued guidelines for the management of diabetes – type 1, type 2, and gestational – which are to be followed by each federal prison in America. The document, most recently updated in 2012, is 50 pages and quite thorough, covering everything from “Definite Indications for Insulin as Initial Therapy” to “Cardinal Signs of Periodontitis.” It also stipulates that frequent monitoring of blood glucose (three times a day) is optimal for a diabetic patient on insulin. Sense August of last year, Jay has been at the medium-security prison in Leavenworth, Kansas. (He transferred from Butner so he could be closer to his family.) He cannot keep his insulin or syringes in his cell but must go to the health center. His problem is the schedule: he is forced to take his insulin injections several hours after his meals (the prison requires a nurse to give them to him), ensuring sharp blood sugar spikes several times a day. He eats breakfast at 6:30 a.m. but does not receive his morning injection until 8 a.m. (5 units of Regular; 20 units of NPH). He eats lunch at 11:30 a.m. but does not get his next shot until 3 p.m. (5 units of Regular), a full 3 ½ hours after his meal. This pattern repeats itself in the evening, when he eats supper at 5 p.m. but cannot take his insulin until 8 p.m. (5 Regular, 18 NPH). I think we're taking the phrase "institutional sales" all wrong. Not that kind of institution. Wouldn't it be ironic if Shkreli went diabetic in jail and then opted to take Afrezza? Poetic justice.
|
|
|
Post by akemp3000 on Apr 9, 2019 9:56:51 GMT -5
I think we're taking the phrase "institutional sales" all wrong. Not that kind of institution. Wouldn't it be ironic if Shkreli went diabetic in jail and then opted to take Afrezza? Poetic justice. That's awesome!!
|
|